Navigation Links
US Court Asked to Decide Whether Childhood Vaccines can Cause Autism

Wearing noise-canceling headphones, Michelle, of Yuma, Arizona, was brought into the courtroom in a wheelchair at the start of the proceedings before the U.S. Court of Federal Claims. She stayed only a short time.

Her parents, Theresa and Michael Cedillo, allege that a preservative called thimerosal that had been used in vaccines weakened their daughter's immune system and prevented her body from clearing the measles virus after she was immunized for the disease at age 15 months.

Today, Michelle suffers from a long list of health problems, including severe autism, inflammatory bowel disease, glaucoma and epilepsy.

The 12-year-old girls parents demand payment under the National Vaccine Injury Compensation Program, a no-fault system that has a $US2.5 billion ($A2.9 billion) fund built up from a tax on vaccines of 75 cents a dose.

The battle royal is a test case having wide ramifications.

Since 1999, more than 4,800 families have filed claims with the government alleging their children developed autism as a result of routine vaccinations containing thimerosal.

The court is being asked to decide whether there is a link between autism and childhood vaccines. If it finds one exists, the families could be eligible for compensation under the Vaccine Injury Compensation Fund, a program established by Congress to ensure an adequate supply of vaccines by safeguarding manufacturers from lawsuits. Under the program, people injured by vaccines receive compensation through a special trust fund.

Autism is characterized by impaired social interaction. Those affected often have trouble communicating, and they exhibit unusual or severely limited activities and interests. Classic symptoms of mercury poisoning include anxiety, fatigue and abnormal irritation, as well as cognitive and motor dysfunction.

Monday's case addresses the theory that the cause of autism is the measles, mumps and rubella va
'"/>




Page: 1 2 3

Related medicine news :

1. Parke-Davis (India) runs into rough weather – Court orders attachment of asset
2. Bihar High Court Intervenes To End Doctors Strike
3. High Court Issues Notice To Centre On Smoking Ban In Films
4. Madras High Court Disapproves of Comparative Advertisements
5. Another British Woman In Court For New Breast Cancer Drug
6. Fizzy Logic For A Perfect Drink: Courtesy Boffins
7. Australian Court Finds Man Guilty of Spreading HIV/AIDS
8. Dare Not Mercy kill – Courtesy: The Care Not Killing Grou
9. Court Orders Private Hospitals To Provide Free Treatment For The Poor
10. Courting Couples Use Valentine’s Day Threat to Their Advantag
11. Mental Health Court Established
Post Your Comments:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...hadrak district now has hopes of pursuing his post...ervened //in his struggle to secure a study loan. ...ed the first position in his graduation in social ...he National Institute of Social Work and Social Sc...
...that by tailoring the intensity of radiation to in...intensive chemotherapy improves outcome for those/...tors led by St. Jude Children’s Research Hospital ...measures for childhood brain cancer medulloblastom...
...s are thought to be inhabited by a rather peculiar... which has peptides attached// together in a patte...nt in the DNA template. This revelation is far rem...e molecular biology textbooks. This discovery ha...
...etic pathway that could help in the eventually hel... The researchers from the Oregon Health & Science ... which demonstrates as to how a genes over-express...o change over from creating hair follicles to crea...
Other Medicine News:Health News:Survival rates improve with better treatment options for medulloblastoma 2Health News:Survival rates improve with better treatment options for medulloblastoma 3Health News:Discovery of A New Genetic Pathway Could Lead To Treatment Of Skin Problems And Cancer 2
(Date:9/3/2008)...results from chronically infected Hepatitis C,pati...ained earlier in 2008, - Study is the first to s... antiviral effect of therapeutic Hepatitis C vac...rt move into a second generation, vaccine formula...gh TLR activation, ...
(Date:9/3/2008)...t. 3 /- Panacea Pharmaceuticals,Inc....r 7,413,737 covering,antibodies against human aspa...rietary human cancer biomarker and therapeutic tar...ion with the Massachusetts Institute of,Technology... to this patent,for development of human cancer di...
(Date:9/3/2008)...ions, Updates Zingo Launch Progress and Adlea ... Conference Call Today at 11:30 am ET, SO...stCall/ -- Anesiva,Inc. (Nasdaq: ANSV ) announce...ns to focus on commercial and late-stage product d...alty pharmaceutical pain management,company. The c...
(Date:9/3/2008)... 3 /- A sub-analysis of,the...nt with prasugrel,compared with clopidogrel signif... attacks (7.4 percent vs. 9.7 percent, p<0.0001), ...he time of an artery-opening,procedure known as pe...,occurred spontaneously during the longer-term mai...
Breaking Medicine Technology:Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 2Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 3Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 6SpectraScience Adds Industry Veteran to Executive Team 21878 1SpectraScience Adds Industry Veteran to Executive Team 21878 2Dont Let Gas Ruin Your Summer BBQ 21876 1Dont Let Gas Ruin Your Summer BBQ 21876 2Cell Therapeutics Inc Repays 2411 0 million Balance of 2008 Convertible Debt 5989 1Cell Therapeutics Inc Repays 2411 0 million Balance of 2008 Convertible Debt 5989 2Fitness a Key Element in Determining Male Diabetics Longevity 21874 1Fitness a Key Element in Determining Male Diabetics Longevity 21874 2
...4 inhibitor, possessing Ki of 27,pM, BOSTON, June ...Inc., a privately held drug discovery biopharmaceu...potent, smart DPP-4 inhibitor,ARI-2243, presented...ciation meeting in Chicago, Illinois. The results ...potent inhibitor of DPP-4 and,produced superior re...
... development of DG041 as an,effective anti-platele... Iceland, June 25, 2007 /PRNewswire-FirstCall/ --,...velopment of,DG041, the company,s Phase II develop...ombosis. The results of the Phase IIa and,clinical...revious,findings demonstrating DG041,s profile as ...
Other Medicine Technology:Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 2Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 3Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 4Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 2Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 3Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 4Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 5Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 6
Surgitie&trade Single Use Ligating Loops without Delivery System with POLYSORB™.
ENDO STITCH&trade Triple-Stitch Single Use Loading Units for use with ENDO Stitch* 10 mm Suturing Device.
ENDO STITCH™ Single Use Loading Units.
...trade; ENDO STITCH™ device is designed for i...d Auto Suture™ trocar sleeves or larger size...he Auto Suture™ ENDO STITCH™ 10 mm sin...DO STITCH™ needle, loaded from a single use ...
Medicine Products: